Publicacións nas que colabora con Elías Quezada González (21)

2024

  1. Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies

    Bioorganic Chemistry, Vol. 146

2023

  1. Phytochemical Analysis and Antiproliferative Activity of Ulex gallii Planch. (Fabaceae), a Medicinal Plant from Galicia (Spain)

    Molecules, Vol. 28, Núm. 1

2021

  1. Curcumin–coumarin hybrid analogues as multitarget agents in neurodegenerative disorders

    Molecules, Vol. 26, Núm. 15

2020

  1. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104

  2. Redox-Active Phenolic Compounds Mediate the Cytotoxic and Antioxidant Effects of Carpodesmia tamariscifolia (=Cystoseira tamariscifolia)

    Chemistry and Biodiversity, Vol. 17, Núm. 7

2019

  1. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels

    Future Medicinal Chemistry, Vol. 11, Núm. 3, pp. 179-191

2017

  1. Synthesis and vasorelaxant and antiplatelet activities of a new series of (4-Benzylphthalazin-1-ylamino)alcohol derivatives

    Medicinal Chemistry Research, Vol. 26, Núm. 8, pp. 1682-1688

2016

  1. Computational Drug Target Screening through Protein Interaction Profiles

    Scientific Reports, Vol. 6

2014

  1. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins

    ChemMedChem, Vol. 9, Núm. 8, pp. 1672-1676

  2. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity

    European Journal of Medicinal Chemistry, Vol. 82, pp. 407-417

2013

  1. MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, invitro Study, and Docking Calculations

    ChemMedChem, Vol. 8, Núm. 6, pp. 956-966

2011

  1. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 4, pp. 1147-1152

2010

  1. Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins

    Molecules, Vol. 15, Núm. 1, pp. 270-279

  2. Synthesis of carbocyclic pyrimidine nucleosides using the Mitsunobu reaction: O2- vs. N1-alkylation

    Helvetica Chimica Acta, Vol. 93, Núm. 2, pp. 309-313

2009

  1. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 12, pp. 3268-3270

  2. Synthesis of regioisomeric functionalized benzodifurans and angelicins

    Helvetica Chimica Acta, Vol. 92, Núm. 7, pp. 1309-1314

2008

  1. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors

    Journal of Medicinal Chemistry, Vol. 51, Núm. 21, pp. 6740-6751

  2. Synthesis and complete assignment of the 1H and 13C NMR signals of some oxopyrancoumarin and oxofuropyrancoumarin derivatives

    Magnetic Resonance in Chemistry, Vol. 46, Núm. 7, pp. 701-705

2007

  1. Assignment of the 1H and 13C NMR signals of some hydroxyphenylcoumarins

    Magnetic Resonance in Chemistry, Vol. 45, Núm. 1, pp. 99-101

2006

  1. Regioselective synthesis of O2- and O6-cyclopyrimidine nucleoside analogues

    Tetrahedron, Vol. 62, Núm. 42, pp. 9949-9952